Kirby D F, Craig R M, Tsang T K, Plotnick B H
JPEN J Parenter Enteral Nutr. 1986 Mar-Apr;10(2):155-9. doi: 10.1177/0148607186010002155.
The results of the first 55 consecutive percutaneous endoscopic gastrostomies (PEGs) that were performed over an 18-month period in a tertiary care center are presented. We followed these cases prospectively to assess the morbidity, mortality, staff acceptance, short-and long-term complications, and cost effectiveness of the technique. Fifty-one (93%) were successful with no mortality. Long-term morbidity included 6/55 (11%) tube extrusions; 5/55 (9%) cellulitis around the catheter site; 5/55 (9%) aspiration pneumonias; and 2/55 (3.6%) clogged tubes requiring replacement. Morbidity was considered minor and easily dealt with in all but five instances (9%) where more prolonged treatment was required. A review of the literature including other techniques used for percutaneous gastrostomy is also presented. It is concluded that percutaneous gastrostomies are relatively safe, cost-effective, and should be given first consideration for long-term enteral therapy in appropriate patients.
本文呈现了在一家三级医疗中心18个月内连续进行的前55例经皮内镜下胃造口术（PEG）的结果。我们对这些病例进行了前瞻性随访，以评估该技术的发病率、死亡率、医护人员的接受度、短期和长期并发症以及成本效益。51例（93%）手术成功，无死亡病例。长期并发症包括55例中有6例（11%）胃管脱出；55例中有5例（9%）导管部位蜂窝织炎；55例中有5例（9%）吸入性肺炎；55例中有2例（3.6%）胃管堵塞需要更换。除5例（9%）需要更长时间治疗的情况外，其他所有病例的并发症都被认为较轻且易于处理。本文还对包括用于经皮胃造口术的其他技术在内的文献进行了综述。结论是，经皮胃造口术相对安全、具有成本效益，对于合适的患者，应作为长期肠内治疗的首选方法。
